Sandoz: Strategic partnership with Just - Evotec extended

(CercleFinance.com) - On Monday Sandoz extended its strategic partnership with Just - Evotec Biologics, the biopharmaceutical manufacturing subsidiary of the German Evotec Group.


Under the terms of this new long-term agreement, Just - Evotec Biologics will supply the Swiss laboratory with the compounds needed to manufacture its generic medicines.

These products will come from the new production unit called "J.POD" that Just - Evotec Biologics has built in Toulouse, and which is entirely dedicated to biological therapies.

Since May 2023, Just - Evotec Biologics and Sandoz have been collaborating under a multi-year agreement on the development and manufacture of biosimilars.

Along with Bristol-Myers Squibb, Sandoz is considered Evotec's largest client.


Copyright (c) 2024 CercleFinance.com. All rights reserved.